IFG Advisory’s Alzamend Neuro ALZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38 Hold
22
– – ﹤0.01% 2277
2026
Q2
$26 Buy
+22
New +$24 ﹤0.01% 2340

Other funds holding ALZN

IFG Advisory's ALZN Position: Q3 2026 in Review

IFG Advisory held its Alzamend Neuro (ALZN) position steady in Q3 2026 at 22 shares worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

IFG Advisory first reported a position in ALZN in Q2 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold ALZN as of Q3 2026.

  • IFG Advisory held 22 shares of Alzamend Neuro worth $38 as of Q3 2026.
  • IFG Advisory left its Alzamend Neuro share count unchanged in Q3 2026.
  • Alzamend Neuro made up ﹤0.01% of IFG Advisory's portfolio in Q3 2026, its #2277 holding.
  • IFG Advisory first reported a position in Alzamend Neuro in Q2 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Alzamend Neuro as of Q3 2026.

Based on IFG Advisory's 13F filing for Q3 2026, filed 9 Nov 2026.